Recardio

Regenerative Cardiac

  • About Us
    • Profile
    • Management
    • Boards
    • Awards
  • Science
    • Approach
    • Background
    • Therapy
  • Clinical
    • Phase 1
    • Phase 2B AMI
    • PHASE 3 (HEAL-AMI)
    • Phase 2B CHF
  • News Center

Mar 28 2022

Recardio at BIO-Europe Spring 2022

San Francisco, March 28, 2022 – Recardio Inc., a late stage clinical-stage life science company focusing on regenerative therapies for cardiovascular diseases, is participating at the BIO-Europe Spring 2022.

Read More

Written by Recardio · Categorized: Uncategorized

  • « Previous Page
  • 1
  • 2
  • Contact us
  • Imprint
  • Data Privacy

© Recardio inc. 2023 · All Rights Reserved

Copyright © 2023 · Recardio on Genesis Framework · WordPress · Log in